“DrugBank’s focus on pharmacogenomics and their ability to capture so much information about it is impressive. I don’t think any other sources give drug interactions the way they do.”
"Instead of focusing on class-based evidence that has been collected over the last 20-30 years, we should be focusing on individual patients and their needs more often. We can use AI and data-driven decision making to help improve outcomes and reduce adverse effects."












